Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada

View ORCID ProfileDavid M. Goldfarb, View ORCID ProfileLouise C. Mâsse, Allison W. Watts, View ORCID ProfileSarah M. Hutchison, Lauren Muttucomaroe, Else S. Bosman, View ORCID ProfileVilte E. Barakauskas, Alexandra Choi, View ORCID ProfileMichael A. Irvine, Frederic Reicherz, View ORCID ProfileDaniel Coombs, View ORCID ProfileCollette O’Reilly, Sadaf Sediqi, Hamid R. Razzaghian, View ORCID ProfileManish Sadarangani, Sheila F. O’Brien, View ORCID ProfilePascal M. Lavoie
doi: https://doi.org/10.1101/2021.06.16.21258861
David M. Goldfarb
1BC Children’s Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
3BC Children’s and Women’s Health Centre, Vancouver, BC, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David M. Goldfarb
Louise C. Mâsse
1BC Children’s Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada
4School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Louise C. Mâsse
Allison W. Watts
5Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah M. Hutchison
1BC Children’s Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada
5Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah M. Hutchison
Lauren Muttucomaroe
5Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Else S. Bosman
5Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vilte E. Barakauskas
1BC Children’s Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
3BC Children’s and Women’s Health Centre, Vancouver, BC, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vilte E. Barakauskas
Alexandra Choi
6Vancouver Coastal Health, Office of the Chief Medical Health Officer, Vancouver, BC, Canada
MD MHSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Irvine
7British Columbia Centre for Disease Control, Vancouver, BC, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael A. Irvine
Frederic Reicherz
5Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Coombs
8Department of Mathematics and Institute of Applied Mathematics, University of British Columbia, Vancouver, BC, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Coombs
Collette O’Reilly
9Vancouver School District, Vancouver, BC, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Collette O’Reilly
Sadaf Sediqi
1BC Children’s Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hamid R. Razzaghian
1BC Children’s Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada
5Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manish Sadarangani
1BC Children’s Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada
3BC Children’s and Women’s Health Centre, Vancouver, BC, Canada
5Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
10Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
BM BCh DPhil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manish Sadarangani
Sheila F. O’Brien
11Epidemiology & Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada
12School of Epidemiology & Public Health, University of Ottawa, Ottawa, Ontario, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascal M. Lavoie
1BC Children’s Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada
3BC Children’s and Women’s Health Centre, Vancouver, BC, Canada
5Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
MDCM, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pascal M. Lavoie
  • For correspondence: plavoie@bcchr.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance Contact-tracing studies suggest minimal secondary transmission in schools. However, there are limited school data accounting for asymptomatic cases, particularly late in the 2020/21 school year, and in the context of uninterrupted in-person schooling and widespread community transmission.

Objectives To determine the SARS-CoV-2 seroprevalence in a sample of school staff, compared to the community, and to COVID-19 rates among all students and staff within the same school population.

Design Incident COVID-19 cases among students and school staff using public health data, with an embedded cross-sectional serosurvey among school staff sampled from February 10 to May 15, 2021, comparing to age, sex and geographic location-matched blood donors sampled in January 2021.

Setting Vancouver School District (British Columbia, Canada) from kindergarten to grade 12.

Participants Active school staff enrolled from February 3 to April 23, 2021.

Main outcome measures SARS-CoV-2 antibodies in a sample of school staff using spike (S)-based testing (unvaccinated staff) or N-based serology testing (vaccinated staff).

Results The incidence of COVID-19 cases among students attending in-person was 9.8 per 1,000 students during the 2020/21 school year (N = 47,280 students), and among staff was 13 per 1,000 since the beginning of the pandemic (N = 7,071 active school staff). In total, 1,689 school staff (64% elementary, 28% secondary, 8.3% school board staff or multiple grades) completed the questionnaire, 78.2% had classroom responsibilities, and spent a median of 17.6 hours in class per week [IQR: 5.0 – 25 hours]. Although 21.5% (363/1,686) reported close contact with a COVID-19 case, only 1.4% (24/1688) of the school staff reported having had a positive viral nucleic acid test. Of this group, five believed they acquired the infection at school. The adjusted seroprevalence in staff who gave blood (1,556/1,689, 92.1%) was 2.3% [95%CI: 1.6 – 3.2%] compared to 2.3% [95%CI: 1.7 – 3.0%] in blood donors.

Conclusion and relevance Despite high reported COVID-19 cases among students and staff, and frequent within-school exposures, we found no detectable increase in seroprevalence among school staff above the community seroprevalence. These findings corroborate claims that, with appropriate mitigation strategies, in-person schooling is not associated with significantly increased risk for school staff.

Question What was the prevalence of COVID-19 infections in school staff who maintained in-person schooling during the 2020/21 school year in Vancouver, British Columbia, and how does it compare to the risk of COVID-19 infection in the community.

Findings As of March 4, 2021, the incidence of COVID-19 cases among school staff was 13 per 1,000 (N = 7,071 school staff) since the beginning of the pandemic. In a cross-sectional seroprevalence analysis from February 10 to May 15, 2021, the adjusted seroprevalence among a sample of school staff (N = 1,556) was 2.3% [95%CI: 1.6 – 3.2%], compared to 2.3% [95%CI: 1.7 – 3.0%] in 1:2 age, sex and geographical location (by postal code)-matched reference group of blood donors.

Meaning We found no detectable increase in seroprevalence among school staff above the community seroprevalence. These findings corroborate claims that, with appropriate mitigation strategies in place, in-person schooling is not associated with significantly higher risk for school staff.

Competing Interest Statement

CO is an employee of the Vancouver School District, but the District was not involved in the design, analysis, interpretation of the data, or the drafting of this manuscript; MS has been an investigator on projects funded by GlaxoSmithKline, Merck, Pfizer, Sanofi-Pasteur, Seqirus, Symvivo and VBI Vaccines. All funds have been paid to his institute, and he has not received any personal payments; Authors declare no relevant conflicts of interest.

Clinical Trial

NA

Funding Statement

The study was funded by the Government of Canada via its COVID-19 Immunity Task Force (to PML). PML and LCM receive a salary from the British Columbia Children's Hospital (BCCH) Foundation through the Investigator Grant Award Program. MS is supported via salary awards from the BC Children's Hospital Foundation, the Canadian Child Health Clinician Scientist Program and the Michael Smith Foundation for Health Research. The BC Children's Hospital Healthy Starts Theme provided some seed funding at the beginning of the study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the University of British Columbia Children's and Women's Research Ethics Board (H20-03593).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding: The study was funded by the Government of Canada via its COVID-19 Immunity Task Force (to PML). PML and LCM receive a salary from the British Columbia Children’s Hospital (BCCH) Foundation through the Investigator Grant Award Program. MS is supported via salary awards from the BC Children’s Hospital Foundation, the Canadian Child Health Clinician Scientist Program and the Michael Smith Foundation for Health Research. The BC Children’s Hospital Healthy Starts Theme provided some seed funding at the beginning of the study.

Data Availability

The data will eventually be made publicly available through the COVID-19 Immunity Task Force

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 18, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada
David M. Goldfarb, Louise C. Mâsse, Allison W. Watts, Sarah M. Hutchison, Lauren Muttucomaroe, Else S. Bosman, Vilte E. Barakauskas, Alexandra Choi, Michael A. Irvine, Frederic Reicherz, Daniel Coombs, Collette O’Reilly, Sadaf Sediqi, Hamid R. Razzaghian, Manish Sadarangani, Sheila F. O’Brien, Pascal M. Lavoie
medRxiv 2021.06.16.21258861; doi: https://doi.org/10.1101/2021.06.16.21258861
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada
David M. Goldfarb, Louise C. Mâsse, Allison W. Watts, Sarah M. Hutchison, Lauren Muttucomaroe, Else S. Bosman, Vilte E. Barakauskas, Alexandra Choi, Michael A. Irvine, Frederic Reicherz, Daniel Coombs, Collette O’Reilly, Sadaf Sediqi, Hamid R. Razzaghian, Manish Sadarangani, Sheila F. O’Brien, Pascal M. Lavoie
medRxiv 2021.06.16.21258861; doi: https://doi.org/10.1101/2021.06.16.21258861

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10779)
  • Forensic Medicine (8)
  • Gastroenterology (583)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (864)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)